Yahoo Web Search

Search results

1. • AbbVie lifts profit forecast after Skyrizi sales beat expectations

     Reuters· 14 minutes ago

     , opens new tab raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the ...

2. • 

     AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth

     Market Watch· 26 minutes ago

     AbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...

3. • AbbVie: Q1 Earnings Snapshot

     Associated Press Finance via Yahoo Finance· 18 minutes ago

     NORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported first-quarter earnings of $1.37 billion. On a per-share basis ...

4. • Abbvie Inc (ABBV) Shares Up Despite Recent Market Volatility – News Heater

     NewsHeater· 4 days ago

     The stock price of Abbvie Inc (NYSE: ABBV) has surged by 1.06 when compared to previous closing price of 164.66, but the company has seen a 2.54% gain in ...

5. • 

     AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study By...

     Investing.com· 18 hours ago

     AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study

6. • 

     AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)

     Seeking Alpha· 22 hours ago

     AbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2.26...

7. • AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts

     ETF DAILY NEWS· 6 days ago

     AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors ...

8. • 

     Cigna to offer Humira rivals with $0 copay at specialty pharmacy

     Reuters· 15 hours ago

     Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...

9. • AbbVie (NYSE:ABBV) Shares Up 1.8%

     ETF DAILY NEWS· 6 days ago

     AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets ...

10. • FY2025 EPS Estimates for AbbVie Inc. (NYSE:ABBV) Lowered by Analyst

      ETF DAILY NEWS· 6 days ago

      AbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at William Blair dropped their FY2025 EPS estimates for shares of AbbVie in a report released ...